Adjustment method for mechanical Boston scientific corporation 30 MHz intravascular ultrasound catheters connected to a Clearview®console

2004 ◽  
Vol 20 (2) ◽  
pp. 83-91 ◽  
Author(s):  
Nico Bruining ◽  
Ronald Hamers ◽  
Tat-Jin Teo ◽  
Pim J. de Feijter ◽  
Patrick W. Serruys ◽  
...  
Keyword(s):  
Intravascular Ultrasound ◽  
Boston Scientific ◽  
Adjustment Method ◽  
Scientific Corporation ◽  
Boston Scientific Corporation

scholarly journals Esophageal Perforation after Using a Single-Use Disposable Duodenoscope

2021 ◽  
pp. 972-977
Author(s):  
Bakht S. Cheema ◽  
Maged Ghali ◽  
Ron Schey ◽  
Ziad Awad ◽  
Bruno Ribeiro
Keyword(s):  
Esophageal Perforation ◽  
Gastroesophageal Junction ◽  
Unintended Consequences ◽  
Tactile Feedback ◽  
Fistula Formation ◽  
Boston Scientific ◽  
Safety Communication ◽  
Scientific Corporation ◽  
Boston Scientific Corporation ◽  
Single Use

The Food and Drug Administration (FDA) has recently released a safety communication recommending transition to duodenoscopes with innovative designs that facilitate or eliminate the need for reprocessing. Thus, there has been a significant amount of development into disposable duodenoscope components and single-use duodenoscopes, with variable tactile feedback. We describe a case of esophageal perforation after using a single-use disposable duodenoscope (EXALT Model D; Boston Scientific Corporation, Marlborough, MA, USA). To our knowledge, this is the first reported case of an esophageal perforation since FDA approval of this device in December 2019. ERCP was performed with the EXALT Model D single-use duodenoscope (Boston Scientific Corporation) by an experienced gastroenterologist. During the procedure, gentle force applied through the gastroesophageal junction caused a liner perforation in the distal esophagus. An esophageal stent was placed with satisfactory wound healing and no fistula formation. There have been a few reports in the last 2 years showing promising results using this device; however, the differences in the tactile feedback, navigation, and pushability of the device may make it prone to unintended consequences.

Frequency, Duration, and Predictors of Newly-Diagnosed Atrial Fibrillation Following Dual-Chamber Pacemaker Implantation in Patients Without a Previous History of Atrial Fibrillation††Conflicts of interest: Dr. Mittal is a consultant for Biotronik and LifeWatch Corporation, Rosemont, Illinois; has received fellowship support from Boston Scientific Corporation, St. Paul, Minnesota, and Medtronic, Minneapolis, Minnesota; and has received speaking honoraria from Boston Scientific Corporation, Medtronic, and St. Jude Medical, St. Paul, Minnesota. Dr. Stein has received speaking honoraria from Boston Scientific Corporation, Medtronic, and St. Jude Medical and is a member of the advisory boards of Boston Scientific Corporation and Medtronic. Dr. Gilliam is a consultant for, has received speaking honoraria from, is a member of the advisory board of, and has received research funding from Boston Scientific Corporation. Stacia Merkel Kraus is a consultant for Boston Scientific Corporation. Drs. Meyer and Christman are employees of Boston Scientific Corporation.

2008 ◽  
Vol 102 (4) ◽  
pp. 450-453 ◽  
Author(s):  
Suneet Mittal ◽  
Kenneth Stein ◽  
F. Roosevelt Gilliam ◽  
Stacia Merkel Kraus ◽  
Timothy Edward Meyer ◽  
...  
Keyword(s):  
Atrial Fibrillation ◽  
Conflicts Of Interest ◽  
Previous History ◽  
Pacemaker Implantation ◽  
Boston Scientific ◽  
Jude Medical ◽  
Advisory Boards ◽  
Scientific Corporation ◽  
Boston Scientific Corporation ◽  
History Of

Intravascular ultrasound in the diagnosis and treatment of central venous diseases

VASA ◽  
2021 ◽  
Vol 50 (1) ◽  
pp. 2-10 ◽  
Author(s):  
Xin Li ◽  
Giuseppe D’Amico ◽  
Cristiano Quintini ◽  
Teresa Diago Uso ◽  
Sameer Gadani ◽  
...  
Keyword(s):  
Intravascular Ultrasound ◽  
Patient Outcomes ◽  
Controlled Trials ◽  
Ivc Filter ◽  
Venous Anatomy ◽  
Central Venous ◽  
Detailed Measurement ◽  
Filter Placement ◽  
Randomized Controlled ◽  
Venous Diseases

Summary: Intravascular ultrasound (IVUS) has been used extensively in coronary applications. Its use in venous applications has increased as endovascular therapy has increasingly become the mainstay therapy for central venous diseases. IVUS has been used for both diagnostic and therapeutic purposes in managing venous stenotic disease, venous occlusive disease, and IVC filter placement and removal. IVUS has been proven to be effective in providing detailed measurement of the venous anatomy, which aid in determining the appropriate size and the approach for venous stent placement. In IVC filter placement, IVUS can provide detailed measurement and guide IVC filter placement in emergent and critical care settings. It also has certain utility in filter removal. At any rate, to date there are only a few studies examining its impact on patient outcomes. Prospective randomized controlled trials are warranted in the future.

Sign in / Sign up

Export Citation Format

Share Document